- NTLA +1.42%
Why Intellia Therapeutics, Inc. (NTLA) Outpaced the Stock Market Today
Yahoo Finance · 19 hours ago
Open | 24.44 |
High | 24.99 |
Low | 23.42 |
Mkt Cap | 2.28B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 23.27 |
52 Wk. Low | 19.37 |
52 Wk. High | 47.48 |
Related stocks
It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.
Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | -1.92M | - |
Net Income | -132.16M | - |
Diluted EPS | -1.46 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$1.38 | - |
Q4 2023 | -$1.45 | -$1.46 |
Q3 2023 | -$1.50 | -$1.38 |
S&P 500^GSPC | 5,127.79+63.59 (+1.26%) |
Dow 30^DJI | 38,675.68+450.02 (+1.18%) |
Nasdaq^IXIC | 16,156.33+315.37 (+1.99%) |
Bitcoin USDBTC-USD | 63,501.64+2.53% |
400.87+0.07% | |
603,000.00-0.56% |